• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Keywords » antidepressant discontinuation

Items Tagged with 'antidepressant discontinuation'

ARTICLES

Research Update

Antidepressant Discontinuation Symptoms

October 26, 2026
Victoria Hendrick, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Victoria Hendrick, MD. Dr. Hendrick has no financial relationships with companies related to this material.

Prior estimates put antidepressant discontinuation symptom rates as high as 56%. A rigorous meta-analysis of nearly 21,000 patients arrives at a very different number—and it changes how clinicians should counsel patients before tapering.


Read More
Hendrick.png
Note From the Editor-in-Chief

Note From the Editor-in-Chief

October 1, 2026
Victoria Hendrick, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Dr. Hendrick weighs in on the federal push for psychiatric deprescribing.


Read More
Clinical Update

On, Off, and On Again: The Hidden Risks of Antidepressant Discontinuation

October 1, 2026
Victoria Hendrick, MD and Michael Gitlin, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Victoria Hendrick, MD. Chief, Inpatient Psychiatry, Olive View-UCLA Medical Center; Editor-in-Chief, The Carlat Hospital Psychiatry Report.

Michael J. Gitlin, MD. Distinguished Professor of Clinical Psychiatry; Director, Mood Disorders Clinic, Geffen School of Medicine, Los Angeles, CA.

Dr. Hendrick and Dr. Gitlin have no financial relationships with companies related to this material.

What do you do when a patient restarts an antidepressant, only to find it doesn't work as well the second time around?


Read More
Research Update

Slow Down and Individualize Antidepressant Deprescribing in Youth

October 1, 2026
Carlat Staff
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Compiled by Carlat Editorial Staff and Reviewed by the Editor-in-Chief and the Editorial Board.

Staff members have no financial relationships with companies related to this material.

Adult tapering rules don’t always translate cleanly to children and teens. A new systematic review asks which antidepressants carry the highest withdrawal risk in youth, and just how slow a taper needs to be.


Read More

How Essential Is Antidepressant Continuation?

June 1, 2022
Michael Posternak, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A landmark study puts a spotlight on whether patients can successfully taper off their antidepressant without relapsing.


Read More
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CAM1e_3DCover_Spiral_sm.png

    Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

    Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2205347851.jpg
    General Psychiatry

    Balancing Focus and Cardiovascular Risk with ADHD Treatment

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.